Results 191 to 200 of about 505,131 (352)

Points of contention: Qualitative research identifying where researchers and research ethics committees disagree about consent waivers for secondary research with tissue and data

, 2020
Angela Ballantyne, Andrew Moore, Karen Bartholomew, Nic Aagaard   +3 more
openalex   +2 more sources

The Impact of Tilburg Frailty on Poststroke Fatigue in First‐Ever Stroke Patients: A Cross‐Sectional Study With Unified Measurement Tools and Improved Statistics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen, Xiao‐Xue Wang, Shao‐Rui Bao, Sui‐Li Lin, Mei‐Chun Shu, Xi‐Xi Ye, Wen‐Jie Cong   +6 more
wiley   +1 more source

Evaluation of Activities and Operations of Institutional Health Research Ethics Committees in Southeast Nigeria. [PDF]

J Empir Res Hum Res Ethics
Ityough JV, Aniwada EA, Ezeome ER.
europepmc   +1 more source

Considerations of sex and gender dimensions by research ethics committees: a scoping review. [PDF]

Int Health, 2022
Saxena A, Lasher E, Somerville C, Heidari S.   +3 more
europepmc   +1 more source

Ethics Committees in Outpatient Medical Practice: a Scoping Review

Milan Arya, Tyler Cholankeril, Marlowe Bogino, Meghan Crnic, Nila A Sathe, Isha Marina Di Bartolo   +5 more
openalex   +2 more sources

Human research ethics committees: Beyond critique to participation

, 2014
Simon Batterbury
openalex   +2 more sources

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini, Emanuela Martinuzzi, Sandra Dhifallah, Abderhmane Slioui, Angela Puma, Luisa Villa, Michele Cavalli, Andra Ezaru, Jérémy Garcia, Manuela Gambella, Federico Torre, Luca Jacopo Pavan, Nicolas Glaichenhaus, Sabrina Sacconi   +13 more
wiley   +1 more source

Perspectives of Research Ethics Committees on the Challenges of Human Genomic Research Participation in Ethiopia. [PDF]

J Empir Res Hum Res Ethics
Dembu HS, Getachew H, Price PJ, Sales J, Wassie L.   +4 more
europepmc   +1 more source

Knowledge and attitudes of Chinese medical postgraduates toward research ethics and research ethics committees: a cross-sectional study. [PDF]

BMC Med Educ, 2023
Liu X, Wang X, Wu Y, Yu H, Yang M, Khoshnood K, Luo E, Wang X.   +7 more
europepmc   +1 more source

The ESC Publications Ethics Committee [PDF]

, 2018
Maarten L. Simoons
openalex   +1 more source